Posted in | News | Biofuels | Renewable Energy

Amyris Partners with GOL to Fly Industry's First Commercial Flight with Renewable Farnesane Fuel

Amyris, an industrial bioscience company, partnered with Brazilian airline, GOL, to fly the industry's first commercial flight with farnesane, the recently approved renewable jet fuel. The first flight, GOL flight 7725, departed from Orlando, Florida on July 30, 2014 at 5:15 PM ET and traveled to Sao Paulo, Brazil.

The Amyris website includes video footage and photos of the refueling using the Amyris-Total renewable jet fuel, departure of the flight and photography of the aircraft.

GOL committed to fly its Boeing 737 fleet with up to a 10 percent blend of the renewable farnesane fuel starting with this initial flight on July 30, 2014. Farnesane can reduce greenhouse gas (GHG) emissions by up to 80 percent compared to petroleum fuels. When blended with Jet A/A1 fuel at 10 percent, farnesane can also reduce particulate matter emissions, decreasing pollution near airports and major metropolitan areas.

The global aviation industry has committed to aggressive goals to reduce its GHG emissions, including achieving carbon neutral growth by 2020 and reducing emissions by 50 percent by 2050 compared to 2005. In addition to improving the efficiency of airplanes and flight operations, this renewable biofuel represents a major opportunity for commercial aviation to reduce emissions. The approved renewable jet fuel is drop-in and can be blended directly with petroleum jet fuel without any changes to airplanes, engines or fueling infrastructure. Amyris will now begin to quantitatively measure the positive impact to GHG emissions and air quality with every flight using the renewable jet fuel.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.